GO:1900249 positive regulation of cytoplasmic translational elongation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900249 describes any process that activates or increases the frequency, rate or extent of cytoplasmic translational elongation, the stage of protein synthesis in which the ribosome adds amino acids to a growing polypeptide.
• Translational elongation is a major control point for gene expression and is tightly coupled to nutrient availability and cellular energy status.
• Positive regulators of elongation include translation factors such as eEF1A and eEF2, and signaling inputs that modulate their activity.
• Dysregulation of cytoplasmic translational elongation is linked to cancer, metabolic stress, and cellular senescence.
• Key experimental approaches include ribosome profiling (Ribo-seq), polysome profiling, and reporter assays to measure elongation rates.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators of this process.
Description
Cytoplasmic translational elongation is the core biosynthetic phase of protein synthesis in which the ribosome sequentially adds amino acids to a nascent polypeptide chain. GO:1900249, positive regulation of cytoplasmic translational elongation, captures any process that activates or increases the frequency, rate or extent of this elongation step. Because elongation consumes a large fraction of cellular energy and amino acids, its positive regulation is tightly integrated with nutrient sensing and growth signaling. Researchers study this term to understand how cells rapidly adjust protein output in response to environmental cues, and how misregulation contributes to disease. The term is distinct from transcriptional control and from other translational stages such as initiation or termination, making it a precise annotation for experiments that directly measure elongation activity.
positive regulation of cytoplasmic translational elongation At A Glance
| GO ID | GO:1900249 |
|---|---|
| GO term | positive regulation of cytoplasmic translational elongation |
| Ontology | biological_process |
| Synonym | activation of cytoplasmic translational elongation; up regulation of cytoplasmic translational elongation; up-regulation of cytoplasmic translational elongation; upregulation of cytoplasmic translational elongation |
| Major function | Increases the rate or extent of the elongation phase of cytoplasmic protein synthesis |
| Parent term | positive regulation of translation |
| Related process | cytoplasmic translational elongation |
| Cellular location | cytoplasm |
| Biological context | Nutrient sensing, growth control, proteostasis |
What Is GO:1900249?
In plain terms, GO:1900249 is the biological process that speeds up or enhances the elongation phase of protein synthesis in the cytoplasm. According to the QuickGO definition, it is any process that activates or increases the frequency, rate or extent of cytoplasmic translational elongation. This includes molecular events that stimulate the ribosome's peptide-bond formation and translocation steps, as well as signaling pathways that enhance the activity or availability of elongation factors. The term is a child of positive regulation of translation and is specific to the cytoplasmic compartment, distinguishing it from mitochondrial or chloroplast translation.
Why Is positive regulation of cytoplasmic translational elongation Important in Cell Biology?
Positive regulation of cytoplasmic translational elongation is important because it allows cells to rapidly increase protein production without new transcription, a critical capacity during growth, stress recovery, and immune responses. Elongation is energetically expensive, so its positive regulation must be precisely controlled; dysregulation can drive oncogenic protein synthesis or contribute to proteotoxic stress in disease. Understanding this process also informs therapeutic strategies targeting translation in cancer and metabolic disorders.
• Enables rapid, transcription-independent increases in protein output during growth and stress.
• Integrates nutrient and energy signals with protein synthesis capacity.
• Contributes to oncogenic transformation when constitutively activated.
• Plays a role in cellular senescence and stress responses.
• Is a target for antibiotics that inhibit bacterial elongation, highlighting its druggability.
• Affects proteostasis and the burden on protein folding and degradation machinery.
• Modulates immune cell activation and cytokine production through translational control.
• Provides a mechanism for synaptic plasticity and memory consolidation via local translation.
• Influences mitochondrial function and mitophagy through coordination with stress pathways.
• Serves as a biomarker and therapeutic target in advanced cancers.
What Happens During positive regulation of cytoplasmic translational elongation?
Elongation factor activation and availability
In simple terms: Helper proteins that drive elongation are switched on or made more available.
Positive regulation often begins with increased activity or availability of elongation factors such as eEF1A and eEF2. Nutrient signals can promote the dephosphorylation of eEF2, enhancing its activity and thereby increasing the rate of translocation. The multi-tasking P-TEFb complex, while primarily known for transcription, also participates in coordinating gene expression programs that support high translational demand.
Ribosome recruitment and polysome formation
In simple terms: More ribosomes are loaded onto mRNA to boost protein output.
Enhanced elongation is frequently accompanied by increased polysome formation, where multiple ribosomes translate the same mRNA simultaneously. This requires sufficient ribosome availability and mRNA accessibility, processes that are influenced by nutrient-sensing pathways. Positive regulators can act by promoting the assembly of elongation-competent 80S ribosomes.
Peptide bond formation and translocation
In simple terms: The ribosome builds the protein chain faster.
At the catalytic core, positive regulation increases the frequency of peptide bond formation and ribosome translocation along the mRNA. This can occur through post-translational modifications of ribosomal proteins or elongation factors that enhance catalytic efficiency. The net effect is a higher rate of amino acid incorporation into nascent polypeptides.
Coupling to nutrient and energy status
In simple terms: The cell checks if it has enough food and energy before speeding up protein building.
Positive regulation of elongation is tightly coupled to nutrient availability. For example, amino acid sufficiency promotes signaling through mTORC1, which in turn stimulates translation elongation by modulating elongation factor activity. This ensures that protein synthesis is not wastefully activated when building blocks are scarce.
Stress-responsive modulation
In simple terms: Under stress, cells can either slow down or selectively speed up protein building.
Stress conditions can either inhibit global elongation or selectively enhance the translation of stress-responsive mRNAs. TIA-1, an RNA-binding protein, has been shown to promote FUNDC1-mediated mitophagy and protect against stress-induced senescence, illustrating how translational control intersects with stress adaptation. Such selective positive regulation helps cells survive adverse conditions.
Key Genes Involved in GO:1900249 positive regulation of cytoplasmic translational elongation
The following genes and proteins are experimentally implicated in the regulation of cytoplasmic translational elongation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EEF1A1 | Delivers aminoacyl-tRNA to the ribosome A site | Core elongation factor; target for measuring elongation rates |
| EEF2 | Catalyzes ribosomal translocation | Phosphorylation-sensitive; key node in nutrient signaling |
| RPS6KB1 | Phosphorylates ribosomal protein S6 | Downstream of mTORC1; links growth signals to translation |
| EIF4EBP1 | Inhibits cap-dependent translation initiation | Indirectly affects elongation capacity by controlling initiation |
| MTOR | Central kinase in nutrient sensing | Regulates elongation via eEF2 and S6K1 |
| TIA1 | RNA-binding protein in stress granules | Modulates translation and mitophagy under stress |
| FUNDC1 | Mitophagy receptor | Linked to TIA-1-mediated stress protection |
| GCN4 (yeast) | Transcriptional activator of amino acid biosynthesis | Model for translational regulation by uORFs |
| GCN2 | eIF2α kinase | Coordinates amino acid starvation with translation |
| VIM | Cell surface vimentin | Marker in circulating tumor cells; linked to translational reprogramming |
| MRG15 | Chromatin reader | Influences apoptosis and mitophagy in pancreatitis |
| P-TEFb (CDK9/Cyclin T1) | Transcription elongation regulator | Coordinates gene expression with translation |
| RPL3 | Ribosomal protein | Structural component of the large subunit |
| RPS6 | Ribosomal protein | Phosphorylated by S6K1; readout of mTORC1 activity |
| EIF2S1 | eIF2α subunit | Phosphorylation inhibits global translation under stress |
| DDIT3 (CHOP) | Stress-induced transcription factor | Links translational stress to apoptosis |
| BCL2L13 | Mitophagy receptor | Potential crosstalk with translational stress |
How Is positive regulation of cytoplasmic translational elongation Regulated?
Positive regulation of cytoplasmic translational elongation is controlled by multiple signaling pathways. The mTORC1 pathway senses amino acids and energy status and promotes elongation by activating S6K1 and inhibiting eEF2 kinase, leading to increased eEF2 activity. Conversely, amino acid starvation activates GCN2, which phosphorylates eIF2α and globally suppresses translation while paradoxically enhancing the translation of specific mRNAs such as GCN4 in yeast. The P-TEFb complex integrates transcriptional and post-transcriptional programs that support high translational output. Stress-responsive RNA-binding proteins like TIA-1 can modulate elongation under adverse conditions. These layers of regulation ensure that elongation is activated only when building blocks and energy are available.
positive regulation of cytoplasmic translational elongation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VIM | Advanced gastric cancer, circulating tumor cells | Knockout in gastric cancer cell lines; xenograft models |
| TIA1 | Stress-induced senescence, mitophagy | Knockout and overexpression in primary fibroblasts |
| MRG15 | Hyperlipidemic acute pancreatitis | Knockout in pancreatic acinar cells; mouse models |
| MTOR | Cancer, metabolic disorders | Point mutation (kinase-dead) knock-in; conditional knockout |
| EEF2 | Cancer, neurodegeneration | Phospho-mimetic knock-in; overexpression |
Cancer
Many cancers exhibit elevated rates of protein synthesis to support rapid proliferation. Positive regulation of cytoplasmic translational elongation contributes to oncogenic transformation by increasing the production of pro-survival and proliferative proteins. Cell surface vimentin, a marker of circulating tumor cells, is associated with advanced gastric cancer and may reflect translational reprogramming. Targeting elongation factors is therefore an active therapeutic strategy.
Cellular Senescence and Stress
Dysregulated translation can promote or protect against cellular senescence depending on context. TIA-1 promotes FUNDC1-mediated mitophagy to protect against stress-induced senescence, indicating that selective translational control can mitigate aging-related damage. Conversely, chronic activation of elongation may accelerate senescence through proteotoxic stress.
Metabolic and Inflammatory Disorders
In hyperlipidemic acute pancreatitis, MRG15 promotes apoptosis through inhibition of mitophagy, a process that may involve translational stress responses. Nutrient overload can dysregulate mTORC1 signaling and elongation, contributing to metabolic disease.
From positive regulation of cytoplasmic translational elongation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for positive regulation of elongation? | CRISPR knockout in cell lines followed by polysome profiling |
| Does a specific phosphorylation site on eEF2 control elongation rate? | Point mutation knock-in (phospho-dead or phospho-mimetic) |
| Does overexpression of gene Y increase global translation? | Doxycycline-inducible overexpression cell line |
| Where does protein Z localize during active elongation? | Endogenous tagged knock-in (e.g., GFP) |
| Does a disease-associated mutation in gene W alter elongation? | Patient-derived iPSCs with isogenic point mutation |
| Can CRISPR library screening identify novel elongation regulators? | Genome-wide knockout library with Ribo-seq readout |
How to Study the positive regulation of cytoplasmic translational elongation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and elongation rate | Global translation profiling |
| Polysome profiling | Distribution of mRNAs across polysomes | Validation of elongation activation |
| Puromycin incorporation | Rate of nascent polypeptide synthesis | Rapid assessment of global translation |
| Phosphoproteomics | Phosphorylation of elongation factors | Identify regulatory sites |
| Luciferase reporter | Real-time elongation activity | Drug screening |
| CRISPR screen | Genes required for elongation | Discovery of novel regulators |
| Immunofluorescence | Localization of elongation factors | Subcellular distribution studies |
| Co-immunoprecipitation | Protein-protein interactions | Identify complexes |
Ribosome Profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of ribosome positions on mRNAs, allowing calculation of elongation rates and detection of pausing. It is the gold standard for studying positive regulation of cytoplasmic translational elongation.
Polysome Profiling
Sucrose gradient centrifugation separates mRNAs by the number of bound ribosomes. An increase in heavy polysomes indicates enhanced elongation or initiation.
Reporter Assays
Luciferase or fluorescent reporters with inducible elongation elements can measure real-time changes in elongation rate in live cells.
Proteomics and Phosphoproteomics
Mass spectrometry can quantify changes in elongation factor abundance and phosphorylation, revealing signaling events that positively regulate elongation.
How CRISPR Can Be Used to Study GO:1900249 positive regulation of cytoplasmic translational elongation
Knockout
CRISPR knockout of candidate genes (e.g., EEF2, MTOR) followed by polysome profiling or Ribo-seq can determine whether the gene is required for positive regulation of cytoplasmic translational elongation. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutation knock-in (e.g., phospho-dead or phospho-mimetic eEF2) allows precise testing of regulatory phosphorylation sites without altering protein levels. This is critical for dissecting signaling mechanisms.
Knock-in
Endogenous tagging of elongation factors with fluorescent or affinity tags enables real-time imaging and interactome analysis in the native context. Knock-in of disease-associated mutations can model human disorders.
Overexpression
Doxycycline-inducible overexpression of positive regulators (e.g., EEF1A1) can test sufficiency for increasing elongation rates and protein output. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports positive regulation of cytoplasmic translational elongation Research
Researchers studying positive regulation of cytoplasmic translational elongation-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cytoplasmic translational elongation research.
Frequently Asked Questions About positive regulation of cytoplasmic translational elongation
What is GO:1900249?
GO:1900249 is the Gene Ontology term for positive regulation of cytoplasmic translational elongation, defined as any process that activates or increases the frequency, rate or extent of cytoplasmic translational elongation.
What genes are involved in positive regulation of cytoplasmic translational elongation?
Key genes include EEF1A1, EEF2, MTOR, RPS6KB1, and TIA1, among others.
How is cytoplasmic translational elongation regulated?
It is regulated by nutrient-sensing pathways such as mTORC1, which modulates elongation factor activity, and by stress-responsive kinases like GCN2.
What diseases are associated with dysregulated translational elongation?
Cancer, metabolic disorders, and cellular senescence are linked to dysregulation of translational elongation.
What methods are used to study positive regulation of cytoplasmic translational elongation?
Common methods include Ribo-seq, polysome profiling, puromycin incorporation, and reporter assays.
Can CRISPR be used to study translational elongation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in elongation.
What is the difference between translational initiation and elongation?
Initiation assembles the ribosome on mRNA, while elongation is the iterative addition of amino acids to the growing polypeptide chain.
Which elongation factor is most studied?
EEF2, which catalyzes translocation, is a major focus due to its regulation by phosphorylation.
How does mTOR regulate translational elongation?
mTORC1 activates S6K1 and inhibits eEF2 kinase, leading to increased eEF2 activity and enhanced elongation.
What is the role of TIA-1 in translation?
TIA-1 modulates translation and promotes mitophagy to protect against stress-induced senescence.
Conclusion
GO:1900249, positive regulation of cytoplasmic translational elongation, is a fundamental biological process that controls the rate of protein synthesis in response to growth and stress signals. Its dysregulation contributes to cancer, metabolic disease, and aging-related phenotypes. Understanding the genes and mechanisms involved requires precise experimental models, and CRISPR-based approaches offer powerful tools for causal interrogation. Continued research in this area promises new therapeutic targets for diseases driven by aberrant translation.
References
- 1. Sahl HG. 1994. Gene-encoded antibiotics made in bacteria.. Ciba Found Symp 186:27-42; discussion 42-53 PMID: 7768156
- 2. Brès V et al.. 2008. The multi-tasking P-TEFb complex.. Curr Opin Cell Biol 20(3):334-40 PMID: 18513937
- 3. Cha S et al.. 2026. TIA-1 promotes FUNDC1-mediated mitophagy to protect against stress-induced cellular senescence.. Exp Mol Med 58(6):1940-1952 PMID: 42249092
- 5. Li H et al.. 2024. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.. J Exp Clin Cancer Res 43(1):129 PMID: 38685125
- 6. Proud CG. 2002. Regulation of mammalian translation factors by nutrients.. Eur J Biochem 269(22):5338-49 PMID: 12423332
- 7. Cigan AM et al.. 1991. Complex formation by positive and negative translational regulators of GCN4.. Mol Cell Biol 11(6):3217-28 PMID: 2038327
- 8. Gu B et al.. 2025. MRG15 promotes cell apoptosis through inhibition of mitophagy in hyperlipidemic acute pancreatitis.. Apoptosis 30(1-2):149-166 PMID: 39487311
